Premarket Mover: Medicinova Inc (MNOV) Down 2.69%

Medicinova Inc (MNOV) has fallen Wednesday morning, with the stock falling -2.69% in pre-market trading to 1.81. MNOV's short-term technical score of 16 indicates that the stock has traded less bullishly over the last month than 84% of stocks on the market. In the Biotechnology industry, which ranks 130 out of 146 industries, Medicinova Inc ranks higher than 27% of stocks. Medicinova Inc has fallen 7.92% over the past month, closing at $1.97 on October 25. During this period of time, the stock fell as low as $1.74 and as high as $2.16. MNOV has an average analyst recommendation of Strong Buy. The company has an average price target of $16.50.

MNOV has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on MNOV!

See Full MNOV Report

Medicinova Inc has a Long-Term Technical rank of 10. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 90% of the market scoring higher. In the Biotechnology industry which is number 131 by this metric, MNOV ranks better than 131% of stocks.

Important Dates for Investors in MNOV:

-Medicinova Inc is set to release earnings on 2024-02-07. Over the last 12 months, the company has reported EPS of $-0.20. -We do not have a set dividend date for Medicinova Inc at this time. Click Here To Get The Full Report on Medicinova Inc (MNOV)